Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
129Xe MRI study of mepolizumab in eosinophilic COPD
ISRCTN17701271Phase 4Recruiting
- Sponsor
- Western University
- Start
- Nov 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mepolizumab in chronic obstructive pulmonary disease (COPD), sponsored by Western University. Started Nov 2026; status: recruiting.
02
Drugs
mepolizumab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ISRCTN17701271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17701271.